Molecular and cellular mechanisms of Macrophage survival in atherosclerosis

Basic Research in Cardiology

Volumn 107, Issue 6, 2012, Pages

  Martinet, Wim ^a   Schrijvers, Dorien M ^a   De Meyer, Guido R Y ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Atherosclerosis; Cell death; Macrophage; Survival

Indexed keywords

ENZYME;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOPHAGY; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; HUMAN; MACROPHAGE; MACROPHAGE MIGRATION; MONOCYTE; NONHUMAN; PHAGOCYTOSIS; PROTEIN SYNTHESIS; REVIEW; UNFOLDED PROTEIN RESPONSE; UPREGULATION;

EID: 84865849121     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-012-0297-x     Document Type: Review

References (113)

1. Anwar A, Keating AK, Joung D, Sather S, Kim GK, Sawczyn KK, Brandao L, Henson PM, Graham DK (2009) Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress. J Leukoc Biol 86:73-79. doi:10.1189/jlb.0608334
2. Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M, Soto E, Ostroff GR, Czech MP (2009) Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 458:1180-1184. doi:10.1038/nature07774
3. Asatryan L, Ziouzenkova O, Duncan R, Sevanian A (2003) Heme and lipid peroxides in hemoglobin-modified low-density lipoprotein mediate cell survival and adaptation to oxidative stress. Blood 102:1732-1739. doi:10.1182/blood-2003- 01-0293 (Pubitemid 37022567)
4. Babaev VR, Chew JD, Ding L, Davis S, Breyer MD, Breyer RM, Oates JA, Fazio S, Linton MF (2008) Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis. Cell Metab 8:492-501. doi:10.1016/j.cmet.2008. 09.005
5. Blanc J, Alves-Guerra MC, Esposito B, Rousset S, Gourdy P, Ricquier D, Tedgui A, Miroux B, Mallat Z (2003) Protective role of uncoupling protein 2 in atherosclerosis. Circulation 107:388-390. doi:10.1161/01. CIR.0000051722.66074. 60 (Pubitemid 36158041)
6. Blanc-Brude OP, Teissier E, Castier Y, Leseche G, Bijnens AP, Daemen M, Staels B, Mallat Z, Tedgui A (2007) IAP survivin regulates atherosclerotic macrophage survival. Arterioscler Thromb Vasc Biol 27:901-907. doi:10.1161/01. ATV.0000258 794.57872.3f (Pubitemid 46606723)
7. Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G (2007) PPARgamma activation primes human monocytes into alternative M2 macrophages with antiinflammatory properties. Cell Metab 6:137-143. doi:10.1016/j.cmet.2007.06. 010 (Pubitemid 47189091)
8. Boullier A, Li Y, Quehenberger O, Palinski W, Tabas I, Witztum JL, Miller YI (2006) Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages. Arterioscler Thromb Vasc Biol 26:1169-1176. doi:10.1161/01. ATV.0000210279.97308.9a (Pubitemid 43732129)
9. Brocheriou I, Maouche S, Durand H, Braunersreuther V, Le NG, Gratchev A, Koskas F, Mach F, Kzhyshkowska J, Ninio E (2011) Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: implication in atherosclerosis. Atherosclerosis 214:316-324. doi:10.1016/j.atherosclerosis.2010.11.023
10. Butcher MJ, Galkina EV (2012) Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta. Front Physiol 3:44. doi: 10.3389/fphys.2012.00044
11. Cantoni O, Tommasini I, Cerioni L, Palomba L, Carloni E, Guidarelli A (2005) Survival pathways triggered by peroxynitrite in cells belonging to the monocyte/macrophage lineage. Comp Biochem Physiol A Mol Integr Physiol 142:118-123. doi:10.1016/j.cbpb.2005.05.037 (Pubitemid 41443570)
12. Cerioni L, Cantoni O (2007) ERK1/2 regulates two sequential steps promoting monocyte survival to peroxynitrite. J Cell Physiol 210:177-182. doi:10.1002/jcp. 20837 (Pubitemid 44904713)
13. Chang TY, Li BL, Chang CC, Urano Y (2009) Acyl-coenzyme A: cholesterol acyltransferases. Am J Physiol Endocrinol Metab 297:E1-E9. doi:10.1152/ajpendo. 90926.2008
14. Chen JH, Riazy M, Smith EM, Proud CG, Steinbrecher UP, Duronio V (2009) Oxidized LDL-mediated macrophage survival involves elongation factor-2 kinase. Arterioscler Thromb Vasc Biol 29:92-98. doi:10.1161/ATVBAHA.108.174599
15. Croons V, Martinet W, Herman AG, Timmermans JP, De Meyer GRY (2007) Selective clearance of macrophages in atherosclerotic plaques by the protein synthesis inhibitor cycloheximide. J Pharmacol Exp Ther 320:986-993. doi:10.1124/jpet.106. 113944 (Pubitemid 46294043)
16. Croons V, Martinet W, Herman AG, Timmermans JP, De Meyer GRY (2009) The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase. J Pharmacol Exp Ther 329:856-864. doi:10.1124/jpet.108.149948
17. Cui D, Thorp E, Li Y, Wang N, Yvan-Charvet L, Tall AR, Tabas I (2007) Pivotal Advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells. J Leukoc Biol 82:1040-1050. doi:10.1189/jlb.0307192 (Pubitemid 350133499)
18. De Meyer I, Martinet W, De Meyer GRY (2012) Therapeutic strategies to deplete macrophages in atherosclerotic plaques. Br J Clin Pharmacol 74:246-263. doi:10.1111/j.1365-2125.2012. 04211.x
19. De Meyer I, Martinet W, Schrijvers DM, Timmermans J-P, Bult H, De Meyer GRY (2012) Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques. Basic Res Cardiol. doi:10.1007/s00395-012-0269-1
20. De Vries-Seimon T, Li Y, Yao PM, Stone E, Wang Y, Davis RJ, Flavell R, Tabas I (2005) Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J Cell Biol 171:61-73. doi:10.1083/jcb.200502078 (Pubitemid 41434602)
21. Dickhout JG, Lhotak S, Hilditch BA, Basseri S, Colgan SM, Lynn EG, Carlisle RE, Zhou J, Sood SK, Ingram AJ, Austin RC (2011) Induction of the unfolded protein response after monocyte to macrophage differentiation augments cell survival in early atherosclerotic lesions. FASEB J 25:576-589. doi: 10.1096/fj.10-159319
22. Dietrich T, Perlitz C, Licha K, Stawowy P, Atrott K, Tachezy M, Meyborg H, Stocker C, Grafe M, Fleck E, Schirner M, Graf K (2007) ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesions. Basic Res Cardiol 102:298-307. doi:10.1007/s00395-007-0652-5 (Pubitemid 46909708)
23. Droin N, Rebe C, Bichat F, Hammann A, Bertrand R, Solary E (2001) Modulation of apoptosis by procaspase-2 short isoform: selective inhibition of chromatin condensation, apoptotic body formation and phosphatidylserine externalization. Oncogene 20:260-269. doi:10.1038/sj.onc.1204066 (Pubitemid 32150271)
24. Erbel C, Dengler TJ, Wangler S, Lasitschka F, Bea F, Wambsganss N, Hakimi M, Bockler D, Katus HA, Gleissner CA (2011) Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability. Basic Res Cardiol 106:125-134. doi:10.1007/s00395-010-0135-y
25. Feig JE, Parathath S, Rong JX, Mick SL, Vengrenyuk Y, Grauer L, Young SG, Fisher EA (2011) Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation 123:989-998. doi:10.1161/CIRCULATIONAHA.110.984146
26. Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, Liu J, Rayner K, Moore K, Garabedian M, Fisher EA (2011) HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc Natl Acad Sci USA 108:7166-7171. doi:10.1073/pnas.1016086108
27. Furukawa Y, Kubo N, Kikuchi J, Tokura A, Fujita N, Sakurabayashi I (2000) Regulation of macrophage-specific gene expression by degenerated lipoproteins. Electrophoresis 21:338-346. doi:10.1002/(SICI) 1522-2683 (20000101) 21:2<338:AIDELPS338> 3.0. CO;2-9 (Pubitemid 30074725)
28. Gerry AB, Leake DS (2008) A moderate reduction in extracellular pH protects macrophages against apoptosis induced by oxidized low density lipoprotein. J Lipid Res 49:782-789. doi:10.1194/jlr. M700349-JLR200
29. Gieseg SP, Amit Z, Yang YT, Shchepetkina A, Katouah H (2010) Oxidant production, oxLDL uptake, and CD36 levels in human monocyte-derived macrophages are downregulated by the macrophagegenerated antioxidant 7, 8-dihydroneopterin. Antioxid Redox Signal 13:1525-1534. doi:10.1089/ars.2009.3065
30. Gieseg SP, Leake DS, Flavall EM, Amit Z, Reid L, Yang YT (2009) Macrophage antioxidant protection within atherosclerotic plaques. Front Biosci 14:1230-1246. doi:10.2741/3305
31. Hamilton JA, Jessup W, Brown AJ, Whitty G (2001) Enhancement of macrophage survival and DNA synthesis by oxidized-low-density-lipoprotein (LDL)-derived lipids and by aggregates of lightly oxidized LDL. Biochem J 355:207-214 (Pubitemid 32304251)
32. Hamilton JA, Myers D, Jessup W, Cochrane F, Byrne R, Whitty G, Moss S (1999) Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler Thromb Vasc Biol 19:98-105. doi:10.1161/01. ATV.19.1.98 (Pubitemid 29031917)
33. Han CY, Pak YK (1999) Oxidation-dependent effects of oxidized LDL: proliferation or cell death. Exp Mol Med 31:165-173 (Pubitemid 30021332)
34. Hetz C (2012) The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 13:89-102. doi:10.1038/nrm3270
35. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251. doi:10.1016/0092-8674 (93) 80066-N (Pubitemid 23320288)
36. Hulten LM, Ullstrom C, Krettek A, van RD, Marklund SL, Dahlgren C, Wiklund O (2005) Human macrophages limit oxidation products in low density lipoprotein. Lipids Health Dis 4:6. doi:10.1186/1476-511X-4-6 (Pubitemid 40594709)
37. Hundal RS, Salh BS, Schrader JW, Gomez-Munoz A, Duronio V, Steinbrecher UP (2001) Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway. J Lipid Res 42:1483-1491 (Pubitemid 34007680)
38. Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN (2005) Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 24:6719-6728. doi:10.1038/sj.onc.1208825 (Pubitemid 41486802)
39. Kadl A, Meher AK, Sharma PR, Lee MY, Doran AC, Johnstone SR, Elliott MR, Gruber F, Han J, Chen W, Kensler T, Ravichandran KS, Isakson BE, Wamhoff BR, Leitinger N (2010) Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res 107:737-746. doi:10.1161/CIRCRESAHA.109.215715
40. Kelly C, Jefferies C, Cryan SA (2011) Targeted liposomal drug delivery to monocytes and macrophages. J Drug Deliv 2011:727241. doi:10.1155/2011/727241
41. Keul P, Lucke S, von Wnuck LK, Bode C, Graler M, Heusch G, Levkau B (2011) Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ Res 108:314-323. doi:10.1161/CIRCRESAHA. 110.235028
42. Keul P, Tolle M, Lucke S, von Wnuck LK, Heusch G, Schuchardt M, van der Giet M, Levkau B (2007) The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 27:607-613. doi:10.1161/01. ATV.0000254679.42583.88
43. Kikuchi J, Furukawa Y, Kubo N, Tokura A, Hayashi N, Nakamura M, Matsuda M, Sakurabayashi I (2000) Induction of ubiquitin-conjugating enzyme by aggregated low density lipoprotein in human macrophages and its implications for atherosclerosis. Arterioscler Thromb Vasc Biol 20:128-134. doi:10.1161/01. ATV.20.1.128 (Pubitemid 30048355)
44. Kinscherf R, Claus R, Wagner M, Gehrke C, Kamencic H, Hou D, Nauen O, Schmiedt W, Kovacs G, Pill J, Metz J, Deigner HP (1998) Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent. FASEB J 12:461-467 (Pubitemid 28146525)
45. Kinscherf R, Deigner HP, Usinger C, Pill J, Wagner M, Kamencic H, Hou D, Chen M, Schmiedt W, Schrader M, Kovacs G, Kato K, Metz J (1997) Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J 11:1317-1328 (Pubitemid 27527895)
46. Kohlstedt K, Trouvain C, Namgaladze D, Fleming I (2011) Adipocyte-derived lipids increase angiotensin-converting enzyme (ACE) expression and modulate macrophage phenotype. Basic Res Cardiol 106:205-215. doi:10.1007/s00395-010- 0137-9
47. Kubo N, Kikuchi J, Furukawa Y, Sakai T, Ohta H, Iwase S, Yamada H, Sakurabayashi I (1997) Regulatory effects of aggregated LDL on apoptosis during foam cell formation of human peripheral blood monocytes. FEBS Lett 409:177-182. doi:10.1016/S0014-5793 (97) 00501-2 (Pubitemid 27273872)
48. 2+ fluxes. Proc Natl Acad Sci USA 91:6569-6573
49. Landsman L, Bar-On L, Zernecke A, Kim KW, Krauthgamer R, Shagdarsuren E, Lira SA, Weissman IL, Weber C, Jung S (2009) CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113:963-972. doi:10.1182/blood-2008-07-170787
50. Ley K, Miller YI, Hedrick CC (2011) Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 31:1506-1516. doi:10.1161/ATVBAHA.110.221127
51. Li W, Zou W, Yang Y, Chai Y, Chen B, Cheng S, Tian D, Wang X, Vale RD, Ou G (2012) Autophagy genes function sequentially to promote apoptotic cell corpse degradation in the engulfing cell. J Cell Biol 197:27-35. doi:10.1083/jcb. 201111053
52. Liao HS, Kodama T, Geng YJ (2000) Expression of class A scavenger receptor inhibits apoptosis of macrophages triggered by oxidized low density lipoprotein and oxysterol. Arterioscler Thromb Vasc Biol 20:1968-1975. doi:10.1161/01. ATV.20.8. 1968 (Pubitemid 30644647)
53. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, Robbins J, Martinez J, Tabas I (2012) Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 15:545-553. doi:10.1016/j.cmet.2012.01.022
54. Llodra J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ (2004) Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA 101:11779-11784. doi: 10.1073/pnas.0403259101 (Pubitemid 39095371)
55. Mantovani A, Garlanda C, Locati M (2009) Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol 29:1419-1423. doi: 10.1161/ATVBAHA.108.180497
56. Martinet W, De Meyer GRY (2009) Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res 104:304-317. doi:10.1161/CIRCRESAHA. 108.188318
57. Martinet W, Knaapen MW, De Meyer GRY, Herman AG, Kockx MM (2001) Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res 88:733-739. doi:10.1161/hh0701.088684 (Pubitemid 32378144)
58. Martinet W, Knaapen MW, De Meyer GRY, Herman AG, Kockx MM (2002) Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106:927-932. doi:10.1161/01. CIR.0000026393.47805.21 (Pubitemid 34925325)
59. Martinet W, Knaapen MW, De Meyer GRY, Herman AG, Kockx MM (2003) Overexpression of the anti-apoptotic caspase-2 short isoform in macrophage-derived foam cells of human atherosclerotic plaques. Am J Pathol 162:731-736. doi:10.1016/S0002-9440 (10) 63869-2 (Pubitemid 36237481)
60. Martinet W, Schrijvers DM, De Meyer GRY (2011) Necrotic cell death in atherosclerosis. Basic Res Cardiol 106:749-760. doi:10.1007/s00395-011-0192-x
61. Martinet W, Schrijvers DM, De Meyer GRY (2011) Pharmacological modulation of cell death in atherosclerosis: a promising approach towards plaque stabilization? Br J Pharmacol 164:1-13. doi:10.1111/j.1476-5381.2011.01342.x
62. Martinet W, Verheye S, De Meyer GRY (2007) Everolimusinduced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy. Autophagy 3:241-244 (Pubitemid 46752686)
63. Martinet W, Verheye S, De Meyer I, Timmermans JP, Schrijvers DM, Van Brussel I, Bult H, De Meyer GRY (2012) Everolimus triggers cytokine release by macrophages: rationale for stents eluting everolimus and a glucocorticoid. Arterioscler Thromb Vasc Biol 32:1228-1235. doi:10.1161/ATVBAHA.112.245381
64. Mizushima N, Komatsu M (2011) Autophagy: renovation of cells and tissues. Cell 147:728-741. doi:10.1016/j.cell.2011.10. 026
65. Moore KJ, Tabas I (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145:341-355. doi:10.1016/j.cell.2011.04. 005
66. Muslin AJ (2008) MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci (Lond) 115:203-218. doi:10.1042/CS20070430
67. Nagy N, Melchior-Becker A, Fischer JW (2010) Long-term treatment with the AT1-receptor antagonist telmisartan inhibits biglycan accumulation in murine atherosclerosis. Basic Res Cardiol 105:29-38. doi:10.1007/s00395-009-0051-1
68. Nguyen XH, Lang PA, Lang KS, Adam D, Fattakhova G, Foger N, Kamal MA, Prilla P, Mathieu S, Wagner C, Mak T, Chan AC, Lee KH (2011) Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination. Blood 118:598-608. doi:10.1182/blood-2010-10- 313643
69. Oksjoki R, Kovanen PT, Lindstedt KA, Jansson B, Pentikainen MO (2006) OxLDL-IgG immune complexes induce survival of human monocytes. Arterioscler Thromb Vasc Biol 26:576-583. doi:10.1161/01. ATV.0000201041.14438.8d
70. Ouimet M, Franklin V, Mak E, Liao X, Tabas I, Marcel YL (2011) Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab 13:655-667. doi:10.1016/j.cmet.2011.03.023
71. Park D, Han CZ, Elliott MR, Kinchen JM, Trampont PC, Das S, Collins S, Lysiak JJ, Hoehn KL, Ravichandran KS (2011) Continued clearance of apoptotic cells critically depends on the phagocyte Ucp2 protein. Nature 477:220-224. doi:10.1038/nature10340
72. Pentikainen MO, Oorni K, Ala-Korpela M, Kovanen PT (2000) Modified LDL: trigger of atherosclerosis and inflammation in the arterial intima. J Intern Med 247:359-370. doi:10.1046/j.1365-2796.2000.00655.x (Pubitemid 30180038)
73. Perlman H, Pagliari LJ, Georganas C, Mano T, Walsh K, Pope RM (1999) FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J Exp Med 190:1679-1688. doi:10.1084/jem.190.11.1679 (Pubitemid 30002349)
74. Poitz DM, Augstein A, Weinert S, Braun-Dullaeus RC, Strasser RH, Schmeisser A (2011) OxLDL and macrophage survival: essential and oxygen-independent involvement of the Hif-pathway. Basic Res Cardiol 106:761-772. doi:10.1007/s00395-011-0186-8
75. -/- mice during disease regression. J Clin Invest 121:2025-2036. doi:10.1172/JCI43802
76. Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN, Gilpin C, Levine B (2007) Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128:931-946. doi:10.1016/j.cell.2006.12.044 (Pubitemid 46341412)
77. Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S, Ting JP, Virgin HW, Kastan MB, Semenkovich CF (2012) Autophagy links inflammasomes to atherosclerotic progression. Cell Metab 15:534-544. doi:10.1016/j.cmet.2012.02. 011
78. Reddy SM, Hsiao KH, Abernethy VE, Fan H, Longacre A, Lieberthal W, Rauch J, Koh JS, Levine JS (2002) Phagocytosis of apoptotic cells by macrophages induces novel signaling events leading to cytokine-independent survival and inhibition of proliferation: activation of Akt and inhibition of extracellular signal-regulated kinases 1 and 2. J Immunol 169:702-713 (Pubitemid 34753425)
79. Riazy M, Chen JH, Yamamato Y, Yamamato H, Duronio V, Steinbrecher UP (2011) OxLDL-mediated survival of macrophages does not require LDL internalization or signalling by major pattern recognition receptors. Biochem Cell Biol 89:387-395. doi:10.1139/o11-035
80. Rios FJ, Gidlund M, Jancar S (2011) Pivotal role for plateletactivating factor receptor in CD36 expression and oxLDL uptake by human monocytes/macrophages. Cell Physiol Biochem 27:363-372. doi:10.1159/000327962
81. Rios FJ, Koga MM, Ferracini M, Jancar S (2012) Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation. PLoS ONE 7:e36632. doi:10.1371/journal.pone.0036632
82. Roiniotis J, Dinh H, Masendycz P, Turner A, Elsegood CL, Scholz GM, Hamilton JA (2009) Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J Immunol 182:7974-7981. doi:10.4049/jimmunol.0804216
83. Saxena A, McMeekin JD, Thomson DJ (2002) Expression of Bcl-x, Bcl-2, Bax, and Bak in endarterectomy and atherectomy specimens. J Pathol 196:335-342. doi:10.1002/path.1040 (Pubitemid 34189424)
84. Schrijvers DM, De Meyer GRY, Herman AG, Martinet W (2007) Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res 73:470-480. doi:10.1016/j.cardiores.2006.09.005 (Pubitemid 46073944)
85. Schrijvers DM, De Meyer GRY, Kockx MM, Herman AG, Martinet W (2005) Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol 25:1256-1261. doi:10.1161/01. ATV.0000166517. 18801.a7 (Pubitemid 40776618)
86. Schrijvers DM, De Meyer GRY, Martinet W (2011) Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arterioscler Thromb Vasc Biol 31:2787-2791. doi: 10.1161/ATVBAHA.111.224899
87. Seimon TA, Wang Y, Han S, Senokuchi T, Schrijvers DM, Kuriakose G, Tall AR, Tabas IA (2009) Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. J Clin Invest 119:886-898. doi:10.1172/JCI37262
88. -/-) mice. Arterioscler Thromb Vasc Biol 32:1142-1149. doi:10.1161/ATVBAHA.111.239111
89. Shimizu S, Eguchi Y, Kamiike W, Funahashi Y, Mignon A, Lacronique V, Matsuda H, Tsujimoto Y (1998) Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc Natl Acad Sci USA 95:1455-1459 (Pubitemid 28103413)
90. Sigruener A, Buechler C, Bared SM, Grandl M, Aslanidis C, Ugocsai P, Gehrmann M, Schmitz G (2007) E-LDL upregulates TOSO expression and enhances the survival of human macrophages. Biochem Biophys Res Commun 359:723-728. doi: 10.1016/j.bbrc.2007.05.169 (Pubitemid 46899011)
91. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn G, Cleutjens JP, van den Akker LH, Corvol P, Wouters BG, Daemen MJ, Bijnens AP (2008) Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol 51:1258-1265. doi:10.1016/j.jacc.2007.12.025 (Pubitemid 351400903)
92. Song Y, Jacob CO (2005) The mouse cell surface protein TOSO regulates Fas/Fas ligand-induced apoptosis through its binding to Fas-associated death domain. J Biol Chem 280:9618-9626. doi:10.1074/jbc. M413609200 (Pubitemid 40409658)
93. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, Kroemer G (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184:1331-1341 (Pubitemid 26354689)
94. Swirski FK, Pittet MJ, Kircher MF, Aikawa E, Jaffer FA, Libby P, Weissleder R (2006) Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci USA 103:10340-10345. doi:10.1073/pnas. 0604260103 (Pubitemid 44051168)
95. Tabas I (2005) Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol 25:2255-2264. doi:10.1161/01. ATV.0000184783. 04864.9f (Pubitemid 41552640)
96. Tabas I (2010) The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circ Res 107:839-850. doi:10.1161/CIRCRESAHA. 110.224766
97. Tano JY, Vazquez G (2011) Requirement for non-regulated, constitutive calcium influx in macrophage survival signaling. Biochem Biophys Res Commun 407:432-437. doi:10.1016/j.bbrc.2011.03.048
98. -/- mice lacking CHOP. Cell Metab 9:474-481. doi:10.1016/j.cmet.2009.03.003
99. -/- mice lacking macrophage Bcl-2. Arterioscler Thromb Vasc Biol 29:169-172. doi:10.1161/ATVBAHA.108.176495
100. Tiwari RL, Singh V, Barthwal MK (2008) Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med Res Rev 28:483-544. doi:10.1002/med.20118 (Pubitemid 351842141)
101. Ujihara M, Nomura K, Yamada O, Shibata N, Kobayashi M, Takano K (2001) Granulocyte-macrophage colony-stimulating factor ensures macrophage survival and generation of the superoxide anion: a study using a monocytic-differentiated HL60 subline. Free Radic Biol Med 31:1396-1404. doi:10.1016/S0891-5849 (01) 00711-0 (Pubitemid 33145309)
102. Van De Parre TJ, Martinet W, Verheye S, Kockx MM, Van Langenhove G, Herman AG, De Meyer GRY (2008) Mitochondrial uncoupling protein 2 mediates temperature heterogeneity in atherosclerotic plaques. Cardiovasc Res 77:425-431. doi:10.1093/cvr/cvm003 (Pubitemid 351197630)
103. Van De Parre T, Martinet W, Verheye S, De Meyer GRY (2007) Uncoupling protein 2-mediated thermogenesis in vulnerable atherosclerotic plaques. Eurointervention 3:275-279
104. Van Herck JL, De Meyer GRY, Martinet W, Bult H, Vrints CJ, Herman AG (2010) Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice. Basic Res Cardiol 105:39-50. doi:10.1007/s00395-009- 0054-y
105. Van Herck JL, De Meyer GRY, Martinet W, Salgado RA, Shivalkar B, De Mondt R, Van De Ven H, Ludwig A, Van der Veken P, Van Vaeck L, Bult H, Herman AG, Vrints CJ (2010) Multi-slice computed tomography with N1177 identifies ruptured atherosclerotic plaques in rabbits. Basic Res Cardiol 105:51-59. doi:10.1007/s00395-009-0052-0
106. Verheye S, De Meyer GRY, Van Langenhove G, Knaapen MW, Kockx MM (2002) In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition. Circulation 105:1596-1601. doi:10.1161/01. CIR.0000012527. 94843. BF (Pubitemid 34297639)
107. Verheye S, Martinet W, Kockx MM, Knaapen MW, Salu K, Timmermans JP, Ellis JT, Kilpatrick DL, De Meyer GRY (2007) Selective clearance of macrophages in atherosclerotic plaques by autophagy. J Am Coll Cardiol 49:706-715. doi: 10.1016/j.jacc.2006.09.047 (Pubitemid 46205042)
108. Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17:1410-1422. doi:10.1038/nm.2538
109. White GE, Greaves DR (2012) Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators. Arterioscler Thromb Vasc Biol 32:589-594. doi:10.1161/ATVBAHA.111.237412
110. Yang H, Chen SC, Tang YQ, Dai YL (2011) Effect of overexpression of human SR-AI on oxLDL uptake and apoptosis in 293T cells. Int Immunopharmacol 11:1752-1757. doi:10.1016/j.intimp. 2011.07.001
111. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132. doi:10.1126/science.275.5303.1129 (Pubitemid 27097312)
112. Zhao M, Eaton JW, Brunk UT (2000) Protection against oxidantmediated lysosomal rupture: a new anti-apoptotic activity of Bcl-2? FEBS Lett 485:104-108. doi:10.1016/S0014-5793 (00) 02195-5
113. Zhou J, Lhotak S, Hilditch BA, Austin RC (2005) Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 111:1814-1821. doi:10.1161/01. CIR.0000160864. 31351. C1 (Pubitemid 40525147)